Rare and orphan diseases affect a small portion of the population but often require specialised treatment, expensive medications, and early diagnosis. In South Africa, medical aid schemes are required to cover Prescribed Minimum Benefits (PMBs), but the treatment for rare diseases is not always fully covered under these benefits.
With over 7,000 identified rare diseases, many of which are genetically inherited and can be lifelong, access to appropriate treatment and medication is critical. However, patients with rare diseases often face challenges when their medical aid does not adequately cover the cost of specialised treatments.
In this article, we will explore how South African medical schemes approach rare diseases and orphan diseases, what coverage options are available, and how patients can access the necessary medications, diagnostic support, and specialist care.
Comparative Overview: How Medical Schemes Cover Rare Diseases
Here’s a breakdown of how leading medical aid providers on MedicalAidOnline.co.za address rare diseases and provide access to medications and diagnostic support. This will help you understand the different approaches of medical aid schemes in covering rare diseases:
| Provider | Treatment for Rare Diseases | Medication Access | Diagnostic Testing & Support |
|---|---|---|---|
| Discovery Health | Coverage for chronic rare conditions through PMBs | Partial coverage for expensive drugs, based on PMB status | Diagnostic support included; specialist referrals allowed |
| Momentum Health | Provides coverage for certain rare diseases | Coverage available for prescribed medication | Diagnostic tests covered under certain conditions |
| Bonitas | Rare disease treatment options through Chronic Care | Chronic medication may be partially covered under PMBs | Diagnostic procedures covered for PMB-listed conditions |
| FedHealth | Offers partial coverage for rare diseases under PMBs | Limited support for high-cost medications | Covers diagnostic tests for rare conditions where applicable |
| Medihelp | Provides rare disease care as part of comprehensive plans | Specialised medications covered, subject to scheme policy | Diagnostic testing available for PMB-listed diseases |
Key Considerations
Prescribed Minimum Benefits (PMBs) are a set of health services that all South African medical aid schemes must cover. The Medical Schemes Act mandates that certain life-threatening conditions and emergency care be provided by all medical aids, but rare diseases often fall outside of this mandated care.
Current PMB Coverage: The PMBs list covers chronic conditions such as diabetes, asthma, and hypertension, but it does not include many rare and orphan diseases like Huntington’s disease or muscular dystrophy.
Percentage of Rare Diseases Covered: According to the Council for Medical Schemes (CMS), less than 15% of rare and orphan diseases are covered under PMBs, leaving the majority of rare disease patients with limited access to necessary treatments.
A report by the South African Rare Disease Association (SARDA) indicates that over 1 in 2,000 South Africans are affected by a rare disease, but only 25% of those affected are able to access sufficient medical treatment under their current medical aid plans.
Accessing Medication for Rare Diseases
Accessing high-cost medications for rare diseases can be difficult. Many rare diseases require expensive specialised treatments that may not be fully covered by standard medical aid plans. Some of the strategies used to address this gap include:
Specialised Care Programs: Some medical aid providers, like Discovery Health, offer managed care programs for rare conditions, providing access to negotiated rates with pharmaceutical companies.
Negotiating with Pharmaceutical Companies: Some plans may work with drug manufacturers to secure discounted rates for patients who need expensive medications for rare diseases.
Private Funding Programs: For conditions not covered under the PMBs, patients may need to apply for private funding or use gap cover to supplement the costs.
According to a study by the South African Pharmaceutical Association (SAPA), the cost of rare disease medications can range from R10,000 to R100,000 per month, depending on the treatment required. This creates a significant financial barrier for many patients, especially if not adequately covered by their medical aid.
Diagnostic Testing Options
Testing for rare diseases can be costly, and not all medical aid schemes will cover the cost of diagnostic tests for conditions not listed under the PMBs. However, some schemes, like Discovery Health and Momentum Health, offer diagnostic testing as part of their comprehensive plans, especially if the rare disease is genetically linked or diagnosed early.
The challenge for many rare disease patients is accessing genetic testing or early diagnostic support, which can help identify conditions that may otherwise go undiagnosed.
A 2024 CMS report highlighted that early genetic testing can reduce diagnostic costs by 50%, but it remains largely unfunded by most medical aids unless it is part of a PMB.
FAQs
Are rare diseases covered under medical aid?
Rare diseases are not always covered under standard medical aid plans, as they often fall outside the Prescribed Minimum Benefits (PMBs). However, some medical schemes, like Discovery Health, offer specialised coverage for certain rare conditions through their managed care programs.
Can I get medication for a rare disease under medical aid?
Yes, medical aid schemes may provide partial coverage for high-cost medications associated with rare diseases. However, the level of cover will depend on the scheme’s policy and whether the medication is listed under the PMB guidelines.
Is diagnostic testing for rare diseases covered?
Diagnostic testing for rare diseases may be covered under certain medical aids, but only if the disease is included in the PMB. For diseases that are not covered, medical aids may require special applications for testing or treatment coverage. While rare diseases pose a unique challenge for both patients and medical aid providers, many South African medical schemes are evolving to provide better coverage. Ensuring that your medical aid covers diagnostic tests, medications, and specialist care for rare diseases is critical to maintaining access to necessary treatments. Visit to compare medical aid plans and gap cover options that offer comprehensive support for rare diseases.